Suppr超能文献

黑色素瘤中的PGC-1α:抗氧化反应和线粒体功能的关键因素。

PGC-1α in Melanoma: A Key Factor for Antioxidant Response and Mitochondrial Function.

作者信息

Torrens-Mas Margalida, González-Hedström Daniel, Abrisqueta Marta, Roca Pilar, Oliver Jordi, Sastre-Serra Jorge

机构信息

Grupo Multidisciplinar de Oncología Traslacional, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Palma, Illes Balears, Spain.

Ciber Fisiopatología Obesidad y Nutrición (CB06/03) Instituto Salud Carlos III, Madrid, Spain.

出版信息

J Cell Biochem. 2017 Dec;118(12):4404-4413. doi: 10.1002/jcb.26094. Epub 2017 Jun 22.

Abstract

Melanocortin 1 receptor (MC1R) and BRAF are common mutations in melanoma. Through different pathways, they each regulate the expression of PGC-1α, which is a key factor in the regulation of mitochondrial biogenesis and the antioxidant response. Our aim was to study the importance of the different regulatory characteristics of MC1R and BRAF on the pathways they regulate in melanoma. For this purpose, ROS production, levels of gene expression and enzymatic activities were analyzed in HBL and MeWo, with wild-type MC1R and BRAF, and A375 cells with mutant MC1R and BRAF. HBL cells showed a functional MC1R-PGC-1α pathway and exhibited the lowest ROS production, probably because of a better mitochondrial pool and the presence of UCP2. On the other hand, MeWo cells showed elevated levels of PGC-1α but also high ROS production, similar to the A375 cells, along with an activated antioxidant response and significantly low levels of UCP2. Finally, A375 cells are mutant for BRAF, and thus showed low levels of PGC-1α. Consequently, A375 cells exhibited poor mitochondrial biogenesis and function, and no antioxidant response. These results show the importance of the activation of the MC1R-PGC-1α pathway for mitochondrial biogenesis and function in melanoma development, as well as BRAF for the antioxidant response regulated by PGC-1α. J. Cell. Biochem. 118: 4404-4413, 2017. © 2017 Wiley Periodicals, Inc.

摘要

黑皮质素1受体(MC1R)和BRAF是黑色素瘤中的常见突变。它们通过不同途径各自调节PGC-1α的表达,而PGC-1α是线粒体生物合成和抗氧化反应调节中的关键因子。我们的目的是研究MC1R和BRAF不同调节特性对它们在黑色素瘤中所调节途径的重要性。为此,在具有野生型MC1R和BRAF的HBL和MeWo细胞以及具有突变型MC1R和BRAF的A375细胞中分析了活性氧(ROS)生成、基因表达水平和酶活性。HBL细胞显示出功能性的MC1R-PGC-1α途径,并且ROS生成最低,这可能是因为线粒体储备更好以及存在解偶联蛋白2(UCP2)。另一方面,MeWo细胞显示出PGC-1α水平升高,但ROS生成也很高,类似于A375细胞,同时抗氧化反应被激活且UCP2水平显著降低。最后,A375细胞是BRAF突变型,因此PGC-1α水平较低。因此,A375细胞表现出线粒体生物合成和功能较差,且没有抗氧化反应。这些结果表明MC1R-PGC-1α途径的激活对黑色素瘤发展中线粒体生物合成和功能的重要性,以及BRAF对由PGC-1α调节的抗氧化反应的重要性。《细胞生物化学杂志》118: 4404 - 4413, 2017。© 2017威利期刊公司。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验